Share This

Hot News

【新股IPO】昭衍新藥6127傳超購逾310倍、凍資1840億擬以招股價上限定價- 香港經濟日報- 即時新聞頻道- 即市財經- 新股IPO @ 2021-02-21T08: Back Hot News
Keyword:昭衍新藥
Concept:財經新聞 , 昭衍新藥入場費
【新股IPO】昭衍新藥6127傳超購逾310倍、凍資1840億 擬以招股價上限定價
昭衍新藥 (新上市編號:06127)啟動招股,招股價介乎133至151元,一手(100股)入場費15,252元,最多集資65.4億元。昭衍新藥首日孖展反應已見不俗,成為新一輪新股焦點,認購昭衍新藥前,不妨先從下文了解一下再決定。
【NOW新聞台】從事藥物非臨床研究服務的昭衍新藥首日公開招股。

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.